surmount-1 tirzepatide weight loss percent 72 weeks reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 - Ard - 2025 - Diabetes, Obesity and Metabolism NEJM on X: "SURMOUNT-1: In

TD1 usually occurs acutely unless it is a continuation of TD2

Semaglutide is a GLP-1 receptorbased therapy that works through pathways involved in appetite regulation, digestion, and glucose metabolism

On Reddit, users told how another Novo drug in development, called CagriSema, had helped reduce inflammation and hunger pangs better than semaglutide

Author HealthCert Education As GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) become more widely prescribed for type 2 diabetes and weight management, general practitioners are increasingly likely to encounter patients experiencing gut-related side effects

However, as with any medical procedure, it is essential to be aware of potential side effects and risks to ensure patient safety and optimal outcomes

The added targets generally correlate with larger weight reductions in trials